Aberdeen Group plc Has $35.42 Million Stock Holdings in Encompass Health Corporation $EHC

Key Points

• Aberdeen Group plc increased its ownership in Encompass Health Corporation by 81.1%, now holding 349,725 shares valued at approximately $35,420,000.
• CEO Mark J. Tarr sold 118,384 shares, reducing his ownership by 18.34% and leaving him with shares worth about $64,054,817.
• Encompass Health announced an increase in its quarterly dividend from $0.17 to $0.19 per share, with the next payment scheduled for October 15th.

Aberdeen Group plc boosted its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 81.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 349,725 shares of the company's stock after buying an additional 156,628 shares during the quarter. Aberdeen Group plc owned 0.35% of Encompass Health worth $35,420,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in EHC. Caitong International Asset Management Co. Ltd grew its stake in shares of Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock valued at $73,000 after purchasing an additional 115 shares during the last quarter. Arlington Trust Co LLC grew its position in Encompass Health by 22.9% in the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after buying an additional 125 shares during the last quarter. IFP Advisors Inc increased its stake in Encompass Health by 5.9% in the 1st quarter. IFP Advisors Inc now owns 2,814 shares of the company's stock valued at $285,000 after buying an additional 158 shares during the period. Merit Financial Group LLC raised its position in Encompass Health by 4.1% during the 1st quarter. Merit Financial Group LLC now owns 4,220 shares of the company's stock worth $427,000 after buying an additional 166 shares during the last quarter. Finally, Sequoia Financial Advisors LLC lifted its stake in shares of Encompass Health by 6.7% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock worth $276,000 after acquiring an additional 172 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on EHC. Truist Financial increased their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a report on Thursday, August 14th. UBS Group upped their target price on Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. KeyCorp upped their price target on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research report on Tuesday, May 27th. Wall Street Zen cut shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Finally, Barclays upped their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company's stock. According to data from MarketBeat, Encompass Health currently has a consensus rating of "Buy" and a consensus target price of $134.00.

Encompass Health Stock Down 0.3%

Shares of EHC stock traded down $0.4110 on Friday, hitting $123.0190. 292,381 shares of the stock were exchanged, compared to its average volume of 813,854. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $124.67. The firm has a market capitalization of $12.39 billion, a P/E ratio of 24.07, a price-to-earnings-growth ratio of 2.16 and a beta of 0.86. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The business has a 50-day moving average of $116.34 and a 200 day moving average of $110.12.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. During the same period last year, the business earned $1.11 earnings per share. The firm's revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. This is an increase from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's dividend payout ratio is presently 13.31%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.